###begin article-title 0
###xml 48 53 48 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD209</italic>
Promoter Variation in the DC-SIGN-Encoding Gene CD209 Is Associated with Tuberculosis
###end article-title 0
###begin p 1
###xml 0 20 0 20 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests:</bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 1
###begin p 2
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Author Contributions:</bold>
Author Contributions: LBB, ON, BG, and LQ designed the study. LBB, ON, LT, KM, BG, and LQ analyzed the data. LBB, CLB, and HQ performed the sequencing and genotyping analyses. PDH and EGH coordinated the collection, clinical information, and DNA extraction of the cohort samples. LBB, ON, CLB, LT, HQ, KM, PDH, EGH, BG, and LQ contributed to writing the paper.
###end p 2
###begin article-title 3
###xml 38 43 38 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD209</italic>
Variants in the DC-SIGN-Encoding Gene CD209 and Susceptibility to Tuberculosis
###end article-title 3
###begin title 4
Background
###end title 4
###begin p 5
###xml 33 60 33 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mycobacterium tuberculosis,</italic>
###xml 170 185 170 185 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 264 280 264 280 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis,</italic>
###xml 33 59 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
###xml 170 185 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 198 203 <span type="species:ncbi:9606">human</span>
###xml 264 279 <span type="species:ncbi:1773">M. tuberculosis</span>
Tuberculosis, which is caused by Mycobacterium tuberculosis, remains one of the leading causes of mortality worldwide. The C-type lectin DC-SIGN is known to be the major M. tuberculosis receptor on human dendritic cells. We reasoned that if DC-SIGN interacts with M. tuberculosis, as well as with other pathogens, variation in this gene might have a broad range of influence in the pathogenesis of a number of infectious diseases, including tuberculosis.
###end p 5
###begin title 6
Methods and Findings
###end title 6
###begin p 7
###xml 35 41 35 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD209,</italic>
###xml 301 306 301 306 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD209</italic>
We tested whether polymorphisms in CD209, the gene encoding DC-SIGN, are associated with susceptibility to tuberculosis through sequencing and genotyping analyses in a South African cohort. After exclusion of significant population stratification in our cohort, we observed an association between two CD209 promoter variants (-871G and -336A) and decreased risk of developing tuberculosis. By looking at the geographical distribution of these variants, we observed that their allelic combination is mainly confined to Eurasian populations.
###end p 7
###begin title 8
Conclusions
###end title 8
###begin p 9
Our observations suggest that the two -871G and -336A variants confer protection against tuberculosis. In addition, the geographic distribution of these two alleles, together with their phylogenetic status, suggest that they may have increased in frequency in non-African populations as a result of host genetic adaptation to a longer history of exposure to tuberculosis. Further characterization of the biological consequences of DC-SIGN variation in tuberculosis will be crucial to better appreciate the role of this lectin in interactions between the host immune system and the tubercle bacillus as well as other pathogens.
###end p 9
###begin p 10
###xml 70 96 70 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mycobacterium tuberculosis</italic>
###xml 70 96 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
Two variants in the gene that encodes DC-SIGN, the major receptor for Mycobacterium tuberculosis on dendritic cells, are associated with susceptibility to TB
###end p 10
###begin title 11
Introduction
###end title 11
###begin p 12
###xml 69 96 69 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mycobacterium tuberculosis,</italic>
###xml 299 300 299 300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030020-b001">1</xref>
###xml 660 661 660 661 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030020-b002">2</xref>
###xml 662 663 662 663 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030020-b003">3</xref>
###xml 873 874 873 874 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030020-b004">4</xref>
###xml 875 876 875 876 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030020-b007">7</xref>
###xml 999 1000 999 1000 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030020-b008">8</xref>
###xml 1221 1222 1221 1222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030020-b009">9</xref>
###xml 1442 1443 1442 1443 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030020-b008">8</xref>
###xml 1444 1446 1444 1446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030020-b010">10</xref>
###xml 1447 1449 1447 1449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030020-b012">12</xref>
###xml 1617 1619 1617 1619 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030020-b013">13</xref>
###xml 1754 1780 1754 1780 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mycobacterium tuberculosis</italic>
###xml 1804 1806 1804 1806 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030020-b014">14</xref>
###xml 1953 1955 1953 1955 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030020-b015">15</xref>
###xml 2080 2082 2080 2082 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030020-b016">16</xref>
###xml 2083 2085 2083 2085 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030020-b017">17</xref>
###xml 2236 2251 2236 2251 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 2253 2255 2253 2255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030020-b018">18</xref>
###xml 2342 2361 2342 2361 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Helicobacter pylori</italic>
###xml 2374 2394 2374 2394 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Klebsiella pneumonia</italic>
###xml 2514 2532 2514 2532 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Leishmania pifanoi</italic>
###xml 2537 2556 2537 2556 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Schistosoma mansoni</italic>
###xml 2558 2560 2558 2560 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030020-b019">19</xref>
###xml 2561 2563 2561 2563 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030020-b027">27</xref>
###xml 2781 2797 2781 2797 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis,</italic>
###xml 2862 2864 2862 2864 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030020-b028">28</xref>
###xml 2865 2867 2865 2867 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030020-b029">29</xref>
###xml 69 95 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
###xml 282 288 <span type="species:ncbi:9606">people</span>
###xml 507 510 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1754 1780 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
###xml 1793 1798 <span type="species:ncbi:9606">human</span>
###xml 2236 2251 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 2342 2361 <span type="species:ncbi:210">Helicobacter pylori</span>
###xml 2429 2434 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 2514 2532 <span type="species:ncbi:5682">Leishmania pifanoi</span>
###xml 2537 2556 <span type="species:ncbi:6183">Schistosoma mansoni</span>
###xml 2781 2796 <span type="species:ncbi:1773">M. tuberculosis</span>
One-third of the world's population is estimated to be infected with Mycobacterium tuberculosis, the etiological agent of tuberculosis (TB). This disease tops the World Health Organization list of deaths due to a single infectious agent, with the death toll between 2 and 3 million people per year [1]. A perplexing, and yet unsolved, feature of TB is that less than 10% of infected individuals develop the disease. Substantial epidemiological evidence supports that host-related factors, such as sex, age, HIV infection, malnutrition, and BCG (bacille Calmette-Guerin) vaccination, influence the balance between the tubercle bacilli and host immune defences [2,3]. In addition, there is increasing evidence that host genetic factors determine differences in host susceptibility to mycobacterial infection and might contribute therefore to the pattern of clinical disease [4-7]. From a host perspective, the innate immunity system acts as the first line of host defense against microbial pathogens [8]. Initial recognition of pathogens by the innate immunity system is mediated by phagocytic cells, such as dendritic cells (DCs) or macrophages, through germline-encoded receptors, known as pattern recognition receptors [9]. DCs bear a range of pattern recognition receptors, such as C-type lectins and Toll-like receptors, involved both in recognition of conserved products of microbial metabolism and in the induction of adaptive immunity [8,10-12]. In particular, C-type lectins detect pathogens by their characteristic carbohydrate structures and internalise them for further antigen processing and presentation [13]. We have recently shown that a prototypic C-type lectin, DC-SIGN (dendritic cell-specific ICAM-3 grabbing nonintegrin), is the major Mycobacterium tuberculosis receptor on human DCs [14]. DC-SIGN is specifically, though not exclusively, expressed on DCs and functions both as a cell adhesion and as a pathogen recognition receptor [15]. As an adhesion receptor, it plays an important role in many DC functions, such as DC-T cell interaction and DC migration [16,17]. Besides its cellular recognition role, DC-SIGN serves as pathogen uptake receptor and mediates interactions with a plethora of pathogens other than M. tuberculosis [18]. Indeed, it has been shown that DC-SIGN allows DCs to capture other bacteria such as Helicobacter pylori and certain Klebsiella pneumonia strains, but also viruses such as HIV-1, Ebola, cytomegalovirus, hepatitis-C, dengue, and SARS-coV, and parasites like Leishmania pifanoi and Schistosoma mansoni [19-27]. In addition, recent data suggest that DC-SIGN may mediate intracellular signalling events leading to cytokine secretion and, on this basis, it has been proposed that the lectin could be used by pathogens, including M. tuberculosis, as a part of an immune evasion strategy to their own advantage [28,29].
###end p 12
###begin p 13
###xml 52 67 52 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 265 270 265 270 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD209</italic>
###xml 325 330 325 330 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD209</italic>
###xml 52 67 <span type="species:ncbi:1773">M. tuberculosis</span>
In light of the ability of DC-SIGN to interact with M. tuberculosis and other pathogens, it is plausible that variation in its gene may influence the pathogenesis of a number of infectious diseases, including TB. We have therefore explored the relationship between CD209 polymorphisms and susceptibility to TB by determining CD209 sequence variation in a cohort of South African Coloured origin.
###end p 13
###begin title 14
Methods
###end title 14
###begin title 15
###xml 0 8 <span type="species:ncbi:9606">Patients</span>
Patients and Methods
###end title 15
###begin p 16
###xml 526 528 526 528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030020-b030">30</xref>
###xml 608 610 608 610 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030020-b031">31</xref>
###xml 717 719 717 719 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030020-b032">32</xref>
###xml 1610 1625 1604 1619 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 1627 1629 1621 1623 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030020-b033">33</xref>
###xml 1630 1632 1624 1626 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030020-b034">34</xref>
###xml 73 81 <span type="species:ncbi:9606">patients</span>
###xml 521 524 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 947 955 <span type="species:ncbi:9606">patients</span>
###xml 1610 1625 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 1653 1656 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1726 1738 <span type="species:ncbi:9606">participants</span>
The study was conducted in a cohort of 711 individuals, including 351 TB patients and 360 healthy controls, living in the Cape Town area. Certain suburbs of metropolitan Cape Town have some of the highest reported incidence rates of TB in the world, despite extensive BCG vaccination. Indeed, our study population comes from two suburbs that have been extensively studied because of their uniform ethnicity (known as South African Coloured) and socio-economic status as well as high incidence of TB and low prevalence of HIV [30]. In addition, our study group represents a present-day homogenous population [31] that previously received genetic input from Khoisan, Malaysian, Bantu, and European descent populations [32]. Thus, it represents a community originating from populations with different susceptibilities to TB and offers a unique opportunity to dissect the contributing genetic variants and their probable geographic/ethnic origins. TB patients were bacteriologically-confirmed (smear-positive and/or culture-positive) to present pulmonary tuberculosis. Their mean age (+/- standard deviation) was 36.7 +/- 10.9 y, and 51.8% were male. Controls were unrelated healthy individuals from the same community, with the same socio-economic status, access to health facilities, and chance of diagnosis, and with neither signs nor previous history of TB (mean age 34.6 +/- 12.5 y, 22% male). The annual risk of infection in this suburb was estimated at 2.5% in 1987 and at 2.8%-3.5% in 1999, and it is therefore highly likely that, in such an environment, the vast majority of controls have been exposed to M. tuberculosis [33,34]. All subjects were HIV-negative and older than 18 y. Informed consent was obtained from all participants, and the study was approved by the ethics committee of the Faculty of Health Sciences, Stellenbosch University (South Africa).
###end p 16
###begin title 17
Laboratory Procedures and Statistical Analysis
###end title 17
###begin p 18
###xml 24 29 24 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD209</italic>
###xml 169 174 169 174 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD209</italic>
###xml 552 554 552 554 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030020-b035">35</xref>
###xml 693 695 693 695 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030020-b036">36</xref>
###xml 961 963 961 963 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030020-b037">37</xref>
###xml 1912 1914 1912 1914 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030020-b035">35</xref>
To identify informative CD209 single nucleotide polymorphisms (SNPs) and to avoid ascertainment bias in the choice of markers to be tested, we first sequenced the whole CD209 genomic region (seven coding exons, flanking intronic regions, and 1,000 base pairs situated 5' of the start codon) in 28 randomly chosen individuals (56 chromosomes). Using polymorphisms with a minimum allele frequency of 0.05, unphased genotypic data were converted into haplotypes using the accelerated EM (Expectation Maximization) algorithm implemented in Haploview v3.1 [35]. To evaluate the accuracy of the EM algorithm, haplotype reconstruction was performed in parallel using the Bayesian statistical method [36] implemented in Phase v.2.1.1. Equivalent results were obtained using both methods, with all haplotypes presenting high levels of statistical support. In order to define a minimal number of SNPs explaining most haplotypic diversity, we used the BEST v1.0 software [37]. Eight haplotype-tagging SNPs were then selected to genotype the entire panel of 711 individuals. Further, potential population stratification between cases and controls was tested by genotyping 25 unlinked SNP markers in the entire study cohort. DNA samples were genotyped by either fluorescence polarization (VICTOR-2TM technology; PerkinElmer, Wellesley, California, United States) or TaqMan (ABI Prism-7000 Sequence Detection System; Applied Biosystems, Foster City, California, United States) assays. Statistical testing for genotypic and haplotypic associations were performed using S TATA 8.2 and Haploview v3.1, respectively. The haplotype frequencies were obtained by summing the fractional likelihood of each haplotype for each individual (i.e., if a particular individual has been determined to have a 40% likelihood of haplotype A and 60% likelihood of haplotype B, 0.4 and 0.6 would be added to the counts for A and B, respectively) [35].
###end p 18
###begin title 19
Results and Discussion
###end title 19
###begin p 20
###xml 28 33 28 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD209</italic>
###xml 202 209 202 209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pmed-0030020-t001">Table 1</xref>
###xml 340 341 340 341 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 352 354 352 354 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;4</sup>
###xml 461 462 461 462 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 693 700 693 700 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pmed-0030020-t002">Table 2</xref>
###xml 846 847 846 847 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 858 860 858 860 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;3</sup>
###xml 975 982 975 982 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pmed-0030020-t002">Table 2</xref>
###xml 1098 1099 1098 1099 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1110 1112 1110 1112 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;3</sup>
###xml 1225 1226 1225 1226 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1237 1239 1237 1239 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;2</sup>
###xml 1252 1254 1252 1254 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;3</sup>
###xml 144 152 <span type="species:ncbi:9606">patients</span>
Two variants located in the CD209 promoter region (-871 A/G and -336 A/G) exhibited a frequency distribution significantly distorted between TB patients and controls, as indicated by a Chi-square test (Table 1). For the -871 variant, genotypes GG and GA were less frequently observed in cases (16.8%) compared to the control group (27.2%) (p = 8.2 x 10-4). For the -336 variant, genotypes GG and GA were more frequent in cases (70.6%) than in controls (61.9%) (p = 0.01). These observations suggest that the alleles -871A (odds ratio [OR]: 1.85; 95% CI: 1.29-2.66) and -336G (OR: 1.48; 95% CI: 1.08-2.02) increase the risk of developing TB in our South African cohort. At the haplotype level (Table 2), a Chi-square test first revealed that the global distribution of haplotype frequencies was significantly different between cases and controls (p = 1.2 x 10-3). One haplotype (H3) turned out to be the main haplotype responsible for such a distorted frequency distribution (Table 2). This haplotype, which contains both -871G and -336A, was found to be strongly associated with the control group (p = 1.6 x 10-3; OR: 1.7; 95% CI: 1.22-2.38). The associations with this haplotype, and with -871, remained highly significant (p = 1.3 x 10-2 and 6.6 x 10-3 respectively), even after the conservative Bonferroni correction for multiple testing.
###end p 20
###begin p 21
###xml 162 164 162 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030020-b031">31</xref>
###xml 165 167 165 167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030020-b032">32</xref>
###xml 979 981 979 981 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030020-b038">38</xref>
###xml 1157 1162 1157 1162 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD209</italic>
###xml 1294 1301 1294 1301 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pmed-0030020-t003">Table 3</xref>
###xml 1316 1317 1314 1315 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1490 1492 1487 1489 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030020-b039">39</xref>
###xml 1505 1506 1502 1503 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1646 1647 1641 1642 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1687 1692 1682 1687 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD209</italic>
###xml 1741 1743 1736 1738 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030020-b039">39</xref>
###xml 1880 1881 1875 1876 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1892 1894 1887 1889 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;2</sup>
###xml 1901 1902 1896 1897 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1913 1915 1908 1910 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;3</sup>
###xml 1920 1921 1915 1916 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1932 1934 1927 1929 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;3</sup>
Although our cohort is considered a present-day homogeneous community that has received genetic contribution from different populations multiple generations ago [31,32], population stratification between cases and controls can be a confounding factor leading to a spurious positive association. Indeed, the use of admixed populations in association-mapping studies can be very useful to identify disease-causing genetic variants that differ in frequency across parental populations. However, when the admixture event is too recent, allelic frequencies can differ coincidentally among cases and controls, reflecting a nonuniform genetic contribution from the parental populations to each subpopulation (i.e., cases and controls), rather than a genuine association between a given genetic variant and the phenotype under study. In this case, the study-cohort is said to present population stratification. To formally test and quantify the levels of background genetic differences [38], if any, between cases and controls, we genotyped the entire cohort for a panel of 25 independent SNPs markers which are (1) not in linkage disequilibrium with the candidate CD209 locus and with any other known gene, (2) randomly distributed along the genome, and (3) polymorphic among the major ethnic groups (Table 3). The mean chi2 statistic among the 25 SNPs for the comparison of allele frequencies between cases and controls, which represents the levels of stratification (mu) between the two groups [39], was 1.25 (p = 0.26), implying that the two groups were not significantly stratified. As an additional correction for stratification, we divided the chi2 values obtained for our candidate gene CD209 by the level of stratification detected (1.25) [39]. Even after such a conservative correction, the associations observed with -336 and -871 as well as with H3 remained significant (-336 p = 2.8 x 10-2; -871 p = 2.7 x 10-3; H3 p = 4.8 x 10-3). These observations support therefore the idea that the -871G and -336A variants are indeed genuinely associated with a protective role against TB.
###end p 21
###begin p 22
###xml 459 466 459 466 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pmed-0030020-t004">Table 4</xref>
###xml 844 846 844 846 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030020-b031">31</xref>
###xml 1177 1184 1177 1184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pmed-0030020-t004">Table 4</xref>
###xml 102 107 <span type="species:ncbi:9606">human</span>
###xml 187 197 <span type="species:ncbi:9598">chimpanzee</span>
###xml 345 351 <span type="species:ncbi:9606">humans</span>
In order to gain insights into the frequency distribution of these two SNPs, we genotyped them in 254 human chromosomes from sub-Saharan Africa, Europe, and East Asia as well as in eight chimpanzee chromosomes. We observed that the -871G and -336A forms, which we propose as offering protection against TB, corresponded to the derived allele in humans; we also observed that these forms are present at higher frequencies in Eurasians as compared to Africans (Table 4). Indeed, the -871G is absent in African populations whereas it reaches high frequencies (20%-40%) in European and Asian populations. Given the absence of the haplotypic combination of -871G and -336A among sub-Saharan Africans, its presence among South African Coloureds suggests that it was introduced through the historically well-known admixture with Europeans and Asians [31]. This observation highlights the power of using admixed populations to better understand historical issues associated with the geographic/ethnic origin of disease-affecting alleles, provided that their prevalence varies in the ancestors of the admixed population (i.e., different frequency of H3 in Africans versus non-Africans; Table 4).
###end p 22
###begin p 23
###xml 129 131 129 131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030020-b040">40</xref>
###xml 321 323 321 323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030020-b041">41</xref>
###xml 324 326 324 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030020-b043">43</xref>
###xml 359 374 359 374 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 454 456 454 456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030020-b042">42</xref>
###xml 858 860 858 860 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030020-b044">44</xref>
###xml 1147 1162 1147 1162 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 1615 1631 1615 1631 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis,</italic>
###xml 1821 1823 1821 1823 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030020-b045">45</xref>
###xml 1862 1864 1862 1864 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030020-b046">46</xref>
###xml 1961 1967 1961 1967 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD209,</italic>
###xml 359 374 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 1147 1162 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 1615 1630 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 1806 1809 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1876 1879 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
In the context of TB, it has been suggested that present-day susceptibility to TB is determined by previous history of exposure [40]. There is fairly convincing evidence that TB has been endemic in Europe for several hundred years, whereas in Africa it has probably been rare before contact was initiated with Europeans [41-43]. It is expected therefore that M. tuberculosis has exerted stronger selective pressures on European than African populations [42]. Our results lend support to this hypothesis and suggest that the protective alleles -871G and -336A increased in frequency in non-African populations as a result of genetic adaptation to a longer period of TB exposure. The potential impact of tuberculosis on the frequency of resistant alleles in European populations has been recently addressed using epidemiological data and statistical modeling [44]. The authors have sought to evaluate the expected changes in resistant allele frequencies, during the 300-y period corresponding to the peak epidemics of TB in Europe. They concluded that if a given resistant allele was at a low frequency in the beginning of an epidemic, selection by M. tuberculosis alone would increase the frequency of this allele, but not enough to bring it to epidemiologically significant levels. In this context, since DC-SIGN is known to interact with a vast range of pathogens, it is indeed likely that the increased frequencies observed today for both -871G and -336A in non-African populations (specially for -871G which is absent in sub-Saharan Africans) may have been driven, not only by the selective pressures imposed by M. tuberculosis, but also by other infectious agents. Indeed, two independent studies have recently reported a genetic association between the -336A variant and protection against parenteral HIV infection [45] and severity of dengue pathogenesis [46]. Although HIV infection, for example, is too recent to have left any signature of selection on CD209, these observations emphasize the possible action of other pathogens in shaping the patterns of variability of this gene.
###end p 23
###begin p 24
###xml 190 192 190 192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030020-b046">46</xref>
###xml 515 530 515 530 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 618 620 618 620 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030020-b047">47</xref>
###xml 497 505 <span type="species:ncbi:9606">patients</span>
###xml 515 530 <span type="species:ncbi:1773">M. tuberculosis</span>
From a functional point of view, the -336A allele has been shown to affect an Sp1-like binding site and to modulate transcriptional activity in vitro by increasing the levels of expression [46]. In the context of TB, increased DC-SIGN expression levels by DCs may result in better capture and processing of mycobacterial antigens, leading to a stronger and wider T-cell response. In addition, we have recently shown that DC-SIGN expression is markedly induced in alveolar macrophages in active TB patients and that M. tuberculosis is preferentially phagocytosed by DC-SIGN-expressing macrophages in these individuals [47]. Thus, the higher prevalence observed among healthy individuals of the -336A variant, which is associated with increased DC-SIGN expression, may underlie an increased efficiency of host phagocytes, such as DCs and macrophages, to control the infection. In addition to the -336A variant, our genetic data showed a strong association of the -871G allele with healthy controls, suggesting also a functional consequence of this variant that, either alone or in combination with -336A, remains to be defined.
###end p 24
###begin p 25
###xml 57 62 57 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD209</italic>
###xml 311 316 311 316 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD209</italic>
###xml 389 391 389 391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030020-b045">45</xref>
###xml 392 394 392 394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030020-b046">46</xref>
###xml 621 626 621 626 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD209</italic>
###xml 708 724 708 724 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis,</italic>
###xml 345 348 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 708 723 <span type="species:ncbi:1773">M. tuberculosis</span>
In conclusion, the significant association found for the CD209 promoter variants together with their phylogenetic status and frequency distribution strongly suggests that the -871G and -336A alleles may reduce the risk of developing TB. More generally, our results, together with those reporting association of CD209 promoter variants with both HIV susceptibility and dengue pathogenesis [45,46] suggest that variation in this lectin may be of crucial importance in the outcome of a number of infections due to DC-SIGN-interacting pathogens. Detailed in vitro and in vivo studies assessing the functional consequences of CD209 variants on the quality of the host immune response against pathogens, including M. tuberculosis, are now required to eventually develop knowledge-based and effective pathway-targeted treatments.
###end p 25
###begin title 26
###xml 0 7 <span type="species:ncbi:9606">Patient</span>
Patient Summary
###end title 26
###begin title 27
Background
###end title 27
###begin p 28
###xml 67 93 67 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mycobacterium tuberculosis</italic>
###xml 67 93 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
###xml 145 151 <span type="species:ncbi:9606">people</span>
###xml 224 230 <span type="species:ncbi:9606">people</span>
###xml 449 455 <span type="species:ncbi:9606">person</span>
###xml 589 595 <span type="species:ncbi:9606">person</span>
Tuberculosis (TB) is an infectious disease caused by the bacterium Mycobacterium tuberculosis. The disease kills between 2 million and 3 million people each year, and almost one-third of the world's population, or 2 billion people, are thought to be infected with the bacterium. However, only about 10% of infected individuals become sick. In the other cases, the body's immune system is capable of controlling the growth of the bacteria. Whether a person's immune system is strong enough to keep the bacterium in check depends on a variety of factors, such as age, how well nourished the person is, other infections, and genetic make-up.
###end p 28
###begin title 29
Why Was This Study Done?
###end title 29
###begin p 30
###xml 630 635 630 635 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD209</italic>
###xml 705 720 705 720 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 69 75 <span type="species:ncbi:9606">person</span>
###xml 305 311 <span type="species:ncbi:9606">person</span>
###xml 705 720 <span type="species:ncbi:1773">M. tuberculosis</span>
Understanding the genetic factors that influence whether an infected person is more or less susceptible to getting sick with TB should help doctors to fight the disease. A number of research groups are studying these genetic factors, and some genes have previously been identified that seem to increase a person's risk of TB. Some of the authors of this study work on a molecule that is part of the immune system. The molecule is called DC-SIGN, and it plays a role in infection of cells in the lung by the Mycobacterium. Together with colleagues who are genetics experts, they wanted to see whether variation in the gene (called CD209) that codes for DC-SIGN influences the risk of someone infected with M. tuberculosis getting sick.
###end p 30
###begin title 31
What Did the Researchers Do and Find?
###end title 31
###begin p 32
###xml 286 301 286 301 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 42 54 <span type="species:ncbi:9606">participants</span>
###xml 124 136 <span type="species:ncbi:9606">participants</span>
###xml 286 301 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 382 394 <span type="species:ncbi:9606">participants</span>
They worked with a group of South African participants from an area close to Cape Town where TB is very common. Half of the participants had TB; the other half did not (even though, because TB is so common in that area, it was likely that most if not all of them had been infected with M. tuberculosis at some point). The researchers compared make-up of the gene for DC-SIGN in all participants and found that some variants of the gene were more common in the group of healthy individuals. In other words, having this particular type of DC-SIGN-encoding gene seemed to protect individuals from getting TB.
###end p 32
###begin title 33
What Does This Mean?
###end title 33
###begin p 34
###xml 212 215 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
DC-SIGN is a central part of the immune system, and others scientists have reported links between variants in the gene for DC-SIGN and the risk of picking up other infectious diseases, including dengue fever and HIV/AIDS. The present study lends more support to the notion that DC-SIGN is a key player in the control of infectious diseases. Understanding more about DC-SIGN could help to develop better treatments for these infections.
###end p 34
###begin title 35
Where Can I Find More Information Online?
###end title 35
###begin p 36
The following Web sites provide information about tuberculosis.
###end p 36
###begin p 37
World Health Organization pages on TB:
###end p 37
###begin p 38

###end p 38
###begin p 39
OMNI pages on TB:
###end p 39
###begin p 40

###end p 40
###begin p 41
Medline PLUS pages on TB:
###end p 41
###begin p 42

###end p 42
###begin p 43
European TB Vaccine Cluster:
###end p 43
###begin p 44

###end p 44
###begin p 45
LBB was supported by a "Fundacao para a Ciencia e a Tecnologia" fellowship (SFRH/BD/18580/2004). This research project has been co-financed by the European Commission, within the 6th Framework Programme (contract no. LSHP-CT-2003-503367). The text represents the authors' views and does not necessarily represent a position of the Commission who will not be liable for the use made of such information. We thank M. Kennedy for help with sample collection, and the South African Medical Research Council and Department of Science and Technology/National Research Foundation (DST/NRF) Centres of Excellence for financial assistance. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 45
###begin title 46
References
###end title 46
###begin article-title 47
Tuberculosis
###end article-title 47
###begin article-title 48
The epidemiological basis of tuberculosis control
###end article-title 48
###begin article-title 49
From exposure to disease: The role of environmental factors in susceptibility to and development of tuberculosis
###end article-title 49
###begin article-title 50
Susceptibility to mycobacterial infections: The importance of host genetics
###end article-title 50
###begin article-title 51
Genetics and genomics in infectious disease susceptibility
###end article-title 51
###begin article-title 52
###xml 30 35 <span type="species:ncbi:9606">human</span>
Genetics of susceptibility to human infectious disease
###end article-title 52
###begin article-title 53
###xml 52 57 <span type="species:ncbi:9606">human</span>
Genetic dissection of immunity to mycobacteria: The human model
###end article-title 53
###begin article-title 54
Innate immune recognition
###end article-title 54
###begin article-title 55
The evolution and genetics of innate immunity
###end article-title 55
###begin article-title 56
Macrophage receptors and immune recognition
###end article-title 56
###begin article-title 57
Toll-like receptors and innate immunity
###end article-title 57
###begin article-title 58
Evolution of the lectin-complement pathway and its role in innate immunity
###end article-title 58
###begin article-title 59
Ligand recognition by antigen-presenting cell C-type lectin receptors
###end article-title 59
###begin article-title 60
###xml 21 47 21 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mycobacterium tuberculosis</italic>
###xml 21 47 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
###xml 60 65 <span type="species:ncbi:9606">human</span>
DC-SIGN is the major Mycobacterium tuberculosis receptor on human dendritic cells
###end article-title 60
###begin article-title 61
Constitutive and induced expression of DC-SIGN on dendritic cell and macrophage subpopulations in situ and in vitro
###end article-title 61
###begin article-title 62
Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses
###end article-title 62
###begin article-title 63
DC-SIGN-ICAM-2 interaction mediates dendritic cell trafficking
###end article-title 63
###begin article-title 64
Self- and nonself-recognition by C-type lectins on dendritic cells
###end article-title 64
###begin article-title 65
###xml 35 40 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells
###end article-title 65
###begin article-title 66
###xml 60 71 <span type="species:ncbi:205488">Ebola virus</span>
C-type lectins DC-SIGN and L-SIGN mediate cellular entry by Ebola virus in cis and in trans
###end article-title 66
###begin article-title 67
###xml 0 21 <span type="species:ncbi:10359">Human cytomegalovirus</span>
Human cytomegalovirus binding to DC-SIGN is required for dendritic cell infection and target cell trans-infection
###end article-title 67
###begin article-title 68
###xml 59 76 <span type="species:ncbi:11103">hepatitis C virus</span>
DC-SIGN and L-SIGN are high-affinity binding receptors for hepatitis C virus glycoprotein E2
###end article-title 68
###begin article-title 69
###xml 25 37 <span type="species:ncbi:12637">dengue virus</span>
###xml 51 56 <span type="species:ncbi:9606">human</span>
DC-SIGN (CD209) mediates dengue virus infection of human dendritic cells
###end article-title 69
###begin article-title 70
###xml 90 135 <span type="species:ncbi:227859">severe acute respiratory syndrome coronavirus</span>
DC-SIGN and DC-SIGNR interact with the glycoprotein of Marburg virus and the S protein of severe acute respiratory syndrome coronavirus
###end article-title 70
###begin article-title 71
###xml 0 19 0 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Helicobacter pylori</italic>
###xml 0 19 <span type="species:ncbi:210">Helicobacter pylori</span>
Helicobacter pylori modulates the T helper cell 1/T helper cell 2 balance through phase-variable interaction between lipopolysaccharide and DC-SIGN
###end article-title 71
###begin article-title 72
Carbohydrate profiling identifies new pathogens that interact with dendritic cell-specific ICAM-3-grabbing nonintegrin on dendritic cells
###end article-title 72
###begin article-title 73
###xml 168 190 168 190 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Leishmania amastigotes</italic>
###xml 139 144 <span type="species:ncbi:9606">human</span>
Dendritic cell (DC)-specific intercellular adhesion molecule 3 (ICAM-3)- grabbing nonintegrin (DC-SIGN, CD209), a C-type surface lectin in human DCs, is a receptor for Leishmania amastigotes
###end article-title 73
###begin article-title 74
Mycobacteria target DC-SIGN to suppress dendritic cell function
###end article-title 74
###begin article-title 75
###xml 68 94 68 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mycobacterium tuberculosis</italic>
###xml 68 94 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
How is the phagocyte lectin keyboard played? Master class lesson by Mycobacterium tuberculosis
###end article-title 75
###begin article-title 76
The use of a geographical information system (GIS) to evaluate the distribution of tuberculosis in a high-incidence community
###end article-title 76
###begin article-title 77
Tuberculosis transmission patterns in a high-incidence area: A spatial analysis
###end article-title 77
###begin article-title 78
###xml 37 45 <span type="species:ncbi:9606">children</span>
Transmission of tuberculosis (TB) to children in a high incidence area
###end article-title 78
###begin article-title 79
Haploview: Analysis and visualization of LD and haplotype maps
###end article-title 79
###begin article-title 80
A comparison of Bayesian methods for haplotype reconstruction from population genotype data
###end article-title 80
###begin article-title 81
Minimal haplotype tagging
###end article-title 81
###begin article-title 82
Use of unlinked genetic markers to detect population stratification in association studies
###end article-title 82
###begin article-title 83
Detecting association in a case-control study while correcting for population stratification
###end article-title 83
###begin article-title 84
Ghetto legacy
###end article-title 84
###begin article-title 85
###xml 53 79 53 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mycobacterium tuberculosis</italic>
###xml 53 79 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
Racial differences in susceptibility to infection by Mycobacterium tuberculosis
###end article-title 85
###begin article-title 86
Genetics and resistance to tuberculosis. Could resistance be enhanced by genetic engineering?
###end article-title 86
###begin article-title 87
History of tuberculosis
###end article-title 87
###begin article-title 88
Historical intensity of natural selection for resistance to tuberculosis
###end article-title 88
###begin article-title 89
###xml 113 148 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Association of DC-SIGN promoter polymorphism with increased risk for parenteral, but not mucosal, acquisition of human immunodeficiency virus type 1 infection
###end article-title 89
###begin article-title 90
A variant in the CD209 promoter is associated with severity of dengue disease
###end article-title 90
###begin article-title 91
###xml 111 119 <span type="species:ncbi:9606">patients</span>
DC-SIGN induction in alveolar macrophages defines a privileged target host cell population for mycobacteria in patients with tuberculosis
###end article-title 91
###begin title 92
Abbreviations
###end title 92
###begin p 93
dendritic cell
###end p 93
###begin p 94
odds ratio
###end p 94
###begin p 95
single nucleotide polymorphism
###end p 95
###begin p 96
tuberculosis
###end p 96
###begin title 97
Figures and Tables
###end title 97
###begin title 98
###xml 34 42 <span type="species:ncbi:9606">Patients</span>
DC-SIGN Genotype Distributions in Patients with Tuberculosis and in Healthy Controls
###end title 98
###begin title 99
###xml 27 35 <span type="species:ncbi:9606">Patients</span>
Haplotype Distributions in Patients with Tuberculosis and in Healthy Controls
###end title 99
###begin title 100
Frequency Distribution in the Study Cohort of the 25 SNPs Used to Test for Population Stratification
###end title 100
###begin title 101
###xml 36 41 36 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD209</italic>
###xml 103 104 103 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 187 188 187 188 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
Frequency Distribution of the Eight CD209 SNPs Genotyped in the Multi-Ethnic Panel of 127 Individuals (n = 254 Chromosomes) as Well as in the 711 Individuals of the South African Cohort (n = 1,422 Chromosomes)
###end title 101
###begin p 102
###xml 128 133 128 133 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD209</italic>
Citation: Barreiro LB, Neyrolles O, Babb CL, Tailleux L, Quach H, et al. (2006) Promoter variation in the DC-SIGN-encoding gene CD209 is associated with tuberculosis. PLoS Med 3(2): e20.
###end p 102

